These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3988396)

  • 21. Disposition of 3-hydroxyquinidine in patients receiving initial intravenous quinidine gluconate for electrophysiology testing of ventricular tachycardia.
    Ackerman BH; Olsen KM; Kennedy EE; Taylor EH; Chen BH; Jordan D; Ackerman DJ
    DICP; 1989 May; 23(5):375-8. PubMed ID: 2728524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition kinetics of quinidine.
    Ueda CT; Hirschfeld DS; Scheinman MM; Rowland M; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinidine elimination in patients with congestive heart failure or poor renal function.
    Kessler KM; Lowenthal DT; Warner H; Gibson T; Briggs W; Reidenberg MM
    N Engl J Med; 1974 Mar; 290(13):706-9. PubMed ID: 4813743
    [No Abstract]   [Full Text] [Related]  

  • 24. Prolonged quinidine half-life with associated toxicity in a patient with hepatic failure.
    Stanek EJ; Simko RJ; DeNofrio D; Pavri BB
    Pharmacotherapy; 1997; 17(3):622-5. PubMed ID: 9165569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quinidine pharmacokinetics in patients with chronic right-ventricular circulatory failure complicated and not complicated by liver cirrhosis].
    Halawa B
    Pol Tyg Lek; 1984 Apr; 39(14):467-70. PubMed ID: 6473202
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetics of microsomal metabolism of quinidine in rats.
    Rakhit A; Mico B
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):109-24. PubMed ID: 4035074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse-phase liquid chromatography and pharmacokinetic study of two hydroxylated analogues of quinidine in dogs.
    Leroyer R; Jarreau C; Pays M; Varoquaux O; Advenier C
    J Pharm Sci; 1984 Jun; 73(6):844-6. PubMed ID: 6547483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.
    Drayer DE; Hughes M; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1980 Jan; 27(1):72-5. PubMed ID: 7351119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of pharmacokinetic parameters of intravenous quinidine and quinine in dogs.
    Clohisy DR; Gibson TP
    J Cardiovasc Pharmacol; 1982; 4(1):107-10. PubMed ID: 6176784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of quinidine metabolites to electrophysiologic responses in human subjects.
    Kavanagh KM; Wyse DG; Mitchell LB; Gilhooly T; Gillis AM; Duff HJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):352-8. PubMed ID: 2776394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine.
    Mikus G; Ha HR; Vozeh S; Zekorn C; Follath F; Eichelbaum M
    Eur J Clin Pharmacol; 1986; 31(1):69-72. PubMed ID: 3780830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high-pressure liquid chromatography method for serum quinidine and (3S)-3-hydroxyquinidine.
    Weidner N; Ladenson JH; Larson L; Kessler G; McDonald JM
    Clin Chim Acta; 1979 Jan; 91(1):7-13. PubMed ID: 761394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
    Fruncillo RJ; Kozin SH; DiGregorio GJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):451-4. PubMed ID: 4081327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption of quinidine and dihydroquinidine in humans.
    Hailey DM; Lea AR; Coles DM; Heaume PE; Smith WJ
    Eur J Clin Pharmacol; 1981; 21(3):195-9. PubMed ID: 7318878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kinetics of elimination of diazepam after intravenous injection in horses].
    Shini S; Klaus AM; Hapke HJ
    Dtsch Tierarztl Wochenschr; 1997 Jan; 104(1):22-5. PubMed ID: 9091281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine.
    Laganière S; Davies RF; Carignan G; Foris K; Goernert L; Carrier K; Pereira C; McGilveray I
    Clin Pharmacol Ther; 1996 Sep; 60(3):255-64. PubMed ID: 8841148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
    Rakhit A; Guentert TW; Holford NH; Verhoeven J; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):315-24. PubMed ID: 6532805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.